| Natural Antidiabetic Agents Studies | Lifetime | 87 | BD 1 | 98.81 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 395 | BD 1 | 98.62 |
| COVID-19 Clinical Research Studies | Lifetime | 564 | BD 3 | 97.89 |
| Computational Drug Discovery Methods | Lifetime | 563 | BD 2 | 97.64 |
| Diverse Scientific Research Studies | Lifetime | 40 | BD 2 | 94.52 |
| Essential Oils and Antimicrobial Activity | Lifetime | 610 | BD 1 | 97.81 |
| Medicinal Plants and Neuroprotection | Lifetime | 177 | BD 2 | 96.14 |
| Ethnobotanical and Medicinal Plants Studies | Lifetime | 257 | BD 3 | 96.61 |
| Phytochemicals and Medicinal Plants | Lifetime | 288 | BD 4 | 92.22 |
| Berberine and alkaloids research | Lifetime | 898 | BD 2 | 79.30 |
| Psidium guajava Extracts and Applications | Lifetime | 532 | BD 4 | 74.61 |
| Pharmacological Effects of Medicinal Plants | Lifetime | 773 | BD 3 | 67.69 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 102 | BD 1 | 99.48 |
| COVID-19 Clinical Research Studies | 2021-2025 | 189 | BD 2 | 98.99 |
| Pharmacological Effects of Natural Compounds | 2021-2025 | 27 | BD 1 | 97.47 |
| Computational Drug Discovery Methods | 2021-2025 | 103 | BD 2 | 98.13 |
| Diverse Scientific Research Studies | 2021-2025 | 8 | BD 1 | 96.62 |
| Bacillus and Francisella bacterial research | 2021-2025 | 28 | BD 2 | 96.20 |
| Natural Antidiabetic Agents Studies | 2021-2025 | 60 | BD 1 | 96.90 |
| Phytochemicals and Antioxidant Activities | 2021-2025 | 212 | BD 3 | 97.35 |
| Long-Term Effects of COVID-19 | 2021-2025 | 483 | BD 2 | 95.63 |
| Cholinesterase and Neurodegenerative Diseases | 2021-2025 | 63 | BD 1 | 95.33 |
| Essential Oils and Antimicrobial Activity | 2021-2025 | 241 | BD 2 | 96.23 |
| Berberine and alkaloids research | 2021-2025 | 17 | BD 1 | 92.08 |
| Medicinal Plants and Neuroprotection | 2021-2025 | 67 | BD 1 | 93.45 |
| Heterocyclic Compound Synthesis and Bioactivity | 2021-2025 | 311 | BD 3 | 95.68 |
| Phytochemistry and Biological Activities | 2021-2025 | 182 | BD 3 | 93.37 |
| Poxvirus research and outbreaks | 2021-2025 | 80 | BD 2 | 93.73 |
| Viral Infections and Vectors | 2021-2025 | 556 | BD 3 | 92.38 |
| Nanoparticles: synthesis and applications | 2021-2025 | 516 | BD 6 | 92.95 |
| SARS-CoV-2 detection and testing | 2021-2025 | 612 | BD 2 | 90.46 |
| Ginkgo biloba and Cashew Applications | 2021-2025 | 42 | BD 1 | 87.30 |
| Cancer therapeutics and mechanisms | 2021-2025 | 230 | BD 2 | 88.02 |
| vaccines and immunoinformatics approaches | 2021-2025 | 265 | BD 5 | 88.43 |
| Herpesvirus Infections and Treatments | 2021-2025 | 346 | BD 3 | 87.78 |
| Alzheimer's disease research and treatments | 2021-2025 | 988 | BD 1 | 90.39 |
| Phytochemicals and Medicinal Plants | 2021-2025 | 147 | BD 5 | 84.85 |
| Viral Infections and Outbreaks Research | 2021-2025 | 453 | BD 5 | 86.43 |
| Cancer Mechanisms and Therapy | 2021-2025 | 351 | BD 2 | 84.53 |
| Antioxidant Activity and Oxidative Stress | 2021-2025 | 292 | BD 2 | 83.09 |
| Alkaloids: synthesis and pharmacology | 2021-2025 | 119 | BD 1 | 81.77 |
| Pineapple and bromelain studies | 2021-2025 | 79 | BD 1 | 81.13 |
| Flavonoids in Medical Research | 2021-2025 | 83 | BD 1 | 76.01 |
| Heavy Metal Exposure and Toxicity | 2021-2025 | 848 | BD 19 | 81.28 |
| Bee Products Chemical Analysis | 2021-2025 | 786 | BD 2 | 80.94 |
| Moringa oleifera research and applications | 2021-2025 | 505 | BD 3 | 79.06 |
| Biochemical Acid Research Studies | 2021-2025 | 74 | BD 1 | 78.16 |
| Bioactive Compounds and Antitumor Agents | 2021-2025 | 384 | BD 5 | 75.15 |
| Tannin, Tannase and Anticancer Activities | 2021-2025 | 55 | BD 1 | 74.73 |
| Nerve injury and regeneration | 2021-2025 | 617 | BD 1 | 74.69 |
| Phytochemical compounds biological activities | 2021-2025 | 270 | BD 2 | 72.36 |
| Ethnobotanical and Medicinal Plants Studies | 2021-2025 | 543 | BD 5 | 74.95 |
| Trace Elements in Health | 2021-2025 | 930 | BD 3 | 72.55 |
| Genomics, phytochemicals, and oxidative stress | 2021-2025 | 770 | BD 2 | 70.99 |
| Curcumin's Biomedical Applications | 2021-2025 | 493 | BD 1 | 70.58 |
| Vitamin C and Antioxidants Research | 2021-2025 | 426 | BD 5 | 69.30 |
| Psidium guajava Extracts and Applications | 2021-2025 | 133 | BD 2 | 64.49 |
| Transgenic Plants and Applications | 2021-2025 | 528 | BD 1 | 64.24 |
| Sirtuins and Resveratrol in Medicine | 2021-2025 | 615 | BD 3 | 62.83 |
| Plant-based Medicinal Research | 2021-2025 | 369 | BD 1 | 61.46 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 589 | BD 1 | 60.89 |
| Biochemical and Structural Characterization | 2021-2025 | 726 | BD 2 | 60.19 |
| Advances in Cucurbitaceae Research | 2021-2025 | 568 | BD 5 | 57.38 |
| Phytochemistry and Bioactive Compounds | 2021-2025 | 285 | BD 2 | 55.86 |
| Biomedical and Engineering Education | 2021-2025 | 995 | BD 1 | 51.88 |
| Cholesterol and Lipid Metabolism | 2021-2025 | 898 | BD 1 | 50.77 |
| Chemotherapy-induced organ toxicity mitigation | 2021-2025 | 593 | BD 2 | 46.63 |
| Medicinal Plants and Bioactive Compounds | 2021-2025 | 606 | BD 8 | 47.30 |
| Magnolia and Illicium research | 2021-2025 | 100 | BD 1 | 44.90 |
| Chromatography in Natural Products | 2021-2025 | 839 | BD 1 | 38.02 |
